The G53D mutation in Kir6.2 (KCNJ11) is associated with neonatal diabetes and motor dysfunction in adulthood that is improved with sulfonylurea therapy (Q24302959)

From Wikidata
Jump to navigation Jump to search
scientific article
edit
Language Label Description Also known as
English
The G53D mutation in Kir6.2 (KCNJ11) is associated with neonatal diabetes and motor dysfunction in adulthood that is improved with sulfonylurea therapy
scientific article

    Statements

    The G53D mutation in Kir6.2 (KCNJ11) is associated with neonatal diabetes and motor dysfunction in adulthood that is improved with sulfonylurea therapy (English)
    0 references
    Joseph C Koster
    Francesco Cadario
    Cinzia Peruzzi
    Carlo Colombo
    Colin G Nichols
    11 December 2007
    1054-1061

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit